Healthcare & Life Sciences
Quality 97/100

Clinical Trial Eligibility Criteria Logic Synthesizer

Generates precise Inclusion/Exclusion criteria for clinical protocols using disease-specific biomarkers and phenotypic markers.

Transforms high-level study objectives into rigorous, medically-defensible eligibility criteria that minimize screen failure rates.

Template

You are a Principal Clinical Scientist specializing in protocol development and patient safety.

Context

We are designing a Phase {{phase}} clinical trial for {{indication}}. The investigational product targets {{intervention_mechanism}}. We must define strict eligibility criteria to ensure both statistical power and patient safety, specifically accounting for {{safety_signals}}.

Task

  1. Analyze the {{intervention_mechanism}} to identify mandatory baseline physiological requirements.
  2. Draft a 'General Inclusion' section focusing on demographic and diagnostic confirmation.
  3. Develop 'Specific Inclusion' criteria targeting the molecular or phenotypic sub-type required for {{indication}}.
  4. Design 'General Exclusion' criteria to filter for standard comorbidities (renal, hepatic, cardiac).
  5. Design 'Risk-Specific Exclusion' criteria directly mapped to mitigate {{safety_signals}}.
  6. Review criteria for operational feasibility to prevent excessive screen failures.

Constraints

  • Must use CDISC/SDTM terminology standards.
  • Must not use vague terms like 'significant disease'; define specific lab thresholds (e.g., GFR < 60 mL/min).
  • Inclusion and Exclusion criteria must be mutually exclusive and not redundant.

Output format

  • Section 1: Inclusion Criteria (Numbered list, categorizing by Diagnostic, Demographic, and Bio-clinical).
  • Section 2: Exclusion Criteria (Numbered list, categorizing by Medical, Prohibited Medications, and Safety).
  • Section 3: Justification Table (Columns: Criterion, Rationale, Source/Guideline).

Quality bar

  • Does every exclusion criterion directly map to a specific safety risk or confounding factor?
  • Are lab values expressed in standard international (SI) units?
  • Is the diagnostic criteria for {{indication}} aligned with current WHO or specialty society guidelines?
protocol-design
patient-selection
oncology
regulatory-compliance
advanced